Extend your brand profile by curating daily news.

Redwood AI Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa

By FisherVista
Redwood AI Corp. signed a non-binding letter of intent for a regional pathogen tracking and AI-enabled outbreak intelligence initiative in Central and East Africa, aiming to improve early detection of infectious disease threats.

Found this article helpful?

Share it with your network and spread the knowledge!

Redwood AI Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) has announced the signing of a non-binding letter of intent with Dr. Placide Sesonga of the University of Global Health Equity in Rwanda to explore the development of a regional pathogen tracking and AI-enabled outbreak intelligence initiative across Central and East Africa, according to a press release.

The proposed collaboration would focus initially on surveillance regions and mobility corridors in Rwanda and the Democratic Republic of the Congo, combining pathogen monitoring, genomic sequencing, geospatial analytics and Redwood’s AI-driven predictive intelligence platform to support earlier detection of emerging infectious disease threats. The parties plan to develop project protocols, deployment frameworks and stakeholder engagement strategies while pursuing potential funding opportunities.

This initiative comes at a critical time when infectious disease outbreaks continue to pose significant threats to global health security. By leveraging artificial intelligence and genomic sequencing, the partnership aims to enhance the ability to detect and respond to outbreaks before they escalate into pandemics. The focus on mobility corridors is particularly important, as human movement along these routes can rapidly spread diseases across borders.

Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

Separately, Redwood announced the resignation of Graydon Bensler from its board of directors, effective immediately.

For more details on the press release, visit https://ibn.fm/4ra9u. The latest news and updates relating to RDWCF are available in the company’s newsroom at https://ibn.fm/RDWCF.

FisherVista

FisherVista

@fishervista